Dr.
Andreas Treml
Andreas Treml received his Ph.D. in
biology from the University of Regensburg in 1997. He worked in the
field of therapeutic oncology and characterized the mode of action
of novel nonsteroidal antiestrogens on steroid hormone receptors
and the involvement of further transcription factors. Prior to
Origenis he developed the high throughput facilities of Morphochem
AG where he was responsible for assay development and adaptation
for parallel library testing. He also developed the automated HTSS®
(high throughput secondary screening) which plays an important role
for compound profiling using the MOREsystem®. As one of the
inventors of the proprietary MOREsystem®, he is responsible for the
integration of biological screening and compound characterization
into the interdisciplinary process.
